LOS ANGELES, CA, Nov. 4, 2009 (Marketwire) --
LOS ANGELES, CA -- (Marketwire) -- 11/04/09 -- MMR Information Systems, Inc. (OTCBB: MMRF) www.mymedicalrecords.com, announced today it has retained Global Research Services LLC, www.grs-cro.com, a full-service clinical trials management organization, to assist the Company in its efforts to accelerate bringing to market its patented anti-CD20 monoclonal antibodies. Anti-CD20 antibodies are useful in treating B-Cell malignancies, including Non-Hodgkin Lymphoma (NHL) and additional B-Cell mediated conditions such as rheumatoid arthritis. Global Research Services specializes in serving sponsors of Phase I-IV research. MMRF's anti-CD20 antibody asset is potentially a candidate for the next generation Rituximab, marketed under the trade name Rituxan® in the United States by Biogen Idec and Genentech (wholly owned member of the Roche Group) and under the name MabThera® by Roche in the rest of the world except Japan, where it is co-marketed by Chugai and Zenyaku Kogyo Co. Ltd. Rituxan is one of the world's most successful monoclonal antibodies with reported total sales in 2008 in excess of US $5.4 billion.
MMR Information Systems recently filed for extension of the Company's Patent Cooperation Treaty (PCT) patent application on anti-CD20 monoclonal antibodies to the national phase through filings in major European, Asian, North American, and South American markets.
Global Research Services operates from offices and/or presence on the ground across six continents of the world, with experience in over 135 protocols with 35 Sponsors in 3400 investigational sites, encompassing all aspects of clinical trials management. The Global team has extensive experience in designing, developing and implementing clinical development programs that accelerate time-to-market for a wide range of new drugs, biologics and medical devices. Global Research Services provides full services from Phase I through final regulatory approval and ultimate commercialization.
Robert H. Lorsch, Chairman and CEO of MMR Information Systems, Inc., noted, "In the Personal Health Records business, the buzzword is 'meaningful use.' With regard to the fighting of cancer, the buzzword could be a 'meaningful difference.' Our health information products have meaning for meaningful use, and we look forward to the possibility that our anti-CD20 antibodies can make a meaningful difference."
About MMR Information Systems, Inc.
MMR Information Systems, Inc. (OTCBB: MMRF), through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, unions and professional organizations and affinity groups.
